An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...

By Stephen Beech Men with advanced prostate cancer have been offered fresh hope thanks to a "promising" new drug combination.

Imagine a future where the moment you’re born, a virtual avatar is created and steadily filled with personalised information ...

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...

The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy that blocks cancer cells from repairing their DNA when damaged - alongside ...

The Alliance for Clinical Trials in Oncology has launched the ASPIRE trial-a large-scale, Phase III clinical study investigating whether adding chemotherapy to current standard treatments can extend ...

But a new study from the University of Oxford suggests that PSA testing is not being used in the most effective way, raising ...

September is Prostate Cancer Awareness Month, and when many men choose to get check-ups.Though the month is nearly over, UAMS ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

Researchers found that late-stage, or distant-stage, prostate cancer is increasing across all age groups, including by approximately 3% annually in men under 55 and by 6% in those 55 and older. The ...

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, and University College London (UCL) today announced that data published online in Cell show that the Decipher Prostate Genomic ...

The media frenzy surrounding former President Joe Biden’s metastatic prostate cancer diagnosis last May didn’t faze one Lancaster resident. Doctors and politicians debated whether Biden and his ...